/Investor DB

Andera Partners — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

T-Knifet-knife.cominSeed · Aug 2021 · $9M✓ verified

T-knife Therapeutics is a biopharmaceutical company developing T cell therapies to treat cancer, with an initial focus on solid tumors.

BiotechHealthtechBerlin, DE

Elisa Kieback(Co-founder & Chief Technology Officer)inThomas Blankenstein(Scientific Founder)Thomas Soloway(Chief Executive Officer)Camille Landis(Chief Business Officer / Chief Financial Officer)inPeggy Sotiropoulou(Chief Scientific Officer)in

Co-investorsVersant VenturesEQT Life SciencesRA CapitalSixty Degree CapitalFidelity Investments

Exciva Gmbhexciva.comSeries A · Oct 2021 · $10M

Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.

BiotechDigital HealthLongevityMedical DevicesHeidelberg, DE

Hans Moebius(Co-founder and CMO, Head of Clinical Operations)inAnton Bespalov(Co-founder and CSO, Head of Regulatory Affairs)in

Co-investorsCARMA FUNDDolby Family VenturesFountain Healthcare PartnersGimvLBBW Venture Capital GmbHLifeArc Ventures+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.